This inventor holds 1 USPTO granted patent. Top assignee: Shenzhen Kangning Hospital (Shenzhen Mental Health Institute, Shenzhen Mental Health Center). Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Huiming Liu: Innovator in Addiction Treatment
Introduction
Huiming Liu is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of addiction treatment through his innovative research and patent.
Latest Patents
Huiming Liu holds a patent titled "Use of miR-132 and miR-212 in preparation of drug for treating addiction." This patent discloses a non-therapeutic method for regulating DAT gene expression in a cell. The method includes the step of increasing or decreasing the amount of miR-132/212 in the cell. Furthermore, it provides a use of the above miRNA, an enhancer thereof, or an attenuator thereof in preparing a drug for regulating the uptake of dopamine by a cell. Additionally, it outlines an application of the above miRNA, the enhancer, or the attenuator in preparing a drug for treating psychoactive substance addiction.
Career Highlights
Huiming Liu is affiliated with Shenzhen Kangning Hospital, which is also known as the Shenzhen Mental Health Institute and Shenzhen Mental Health Center. His work at this institution focuses on mental health and addiction treatment, where he applies his research findings to improve patient outcomes.
Collaborations
Some of his notable coworkers include Xiaojian Jia and Han Rong, who contribute to the collaborative efforts in research and development within the field of mental health.
Conclusion
Huiming Liu's innovative work in the treatment of addiction through his patented methods showcases his commitment to advancing mental health care. His contributions are vital in the ongoing battle against substance addiction, and his research continues to inspire future developments in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile